Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
PLN 0.89
Key Takeaways
Risk factor
Very high price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Greatly overvalued vs peers
Data is available to registered users only
Data is available to registered users only
About
onesano S.A. engages in the research and development in the areas of dietetics, animal nutrition, bioremediation, and agrotechnological processes in Poland. The company provides human dietary supplement products under the Estrovita brand. It also offers Yarrowia Equinox; Yarrowia Canifelox; and Yarrowia Farminox; and dietary supplements, food additives, functional foods, and cosmetic raw materials. The company...
Company Valuation
Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers.
Data is available to registered users only
